Sanofi India informs about disclosure

24 Apr 2025 Evaluate
In compliance with Regulation 30 of the SEBI (LODR) Regulations, Sanofi India has submitted the disclosure regarding Order issued by the Commissioner Central GST & Central Excise, Vadodara II. The matter was remanded by CESTAT to the commissioner for examination regarding the reversal of CENVAT credit. Following the remand, the commissioner confirmed the demand of Rs. 5,25,70,852 along with an equivalent penalty. While the matter was reconsidered, the commissioner proceeded to confirm the demand and penalty as stated.

The above information is a part of company’s filings submitted to BSE.

Sanofi India Share Price

4334.40 -37.30 (-0.85%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×